glp 1 gip dual agonist weight loss GIPR/GLP-1R therapies for diabetes and loss—chemistry, physiology, and clinical applications 🔴Comparison of GLP-1R Mono-Agonist vs.
Description
Retatrutide also remains investigational, with ClinicalTrials.gov listing active or recently updated Phase 3 research records as of May 2026
Florida Surgery and Weight Loss Center Dr
This lack of research raises concerns because non-diabetic patients face different risks and benefits than diabetic patients
Kohler et al., 2017)
